Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer: Breakthrough Pain”

Showing 20 of 0 results

Not applicableStudy completedNCT00994760
What this trial is testing

Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years

Who this might be right for
Breakthrough PainCancer
Takeda 131
Large-scale testing (Phase 3)Study completedNCT01429051
What this trial is testing

A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain

Who this might be right for
Break Through PainCancer
Takeda 46
Large-scale testing (Phase 3)Study completedNCT00236145
What this trial is testing

Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain

Who this might be right for
Breakthrough Pain
Cephalon
Post-approval studies (Phase 4)Ended earlyNCT01812759
What this trial is testing

Fentanyl for Breakthrough Pain in the Emergency Department

Who this might be right for
Pain
M.D. Anderson Cancer Center 3
Post-approval studies (Phase 4)WithdrawnNCT01839552
What this trial is testing

An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients.

Who this might be right for
Pain
University of Louisville
Not applicableUnknownNCT01698645
What this trial is testing

Patient Satisfaction and Quality of Life Impact - PecFent®

Who this might be right for
Breakthrough Cancer Pain
Archimedes Development Ltd 150
Post-approval studies (Phase 4)Study completedNCT00576173
What this trial is testing

An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients

Who this might be right for
Pain
Johnson & Johnson Taiwan Ltd 60
Post-approval studies (Phase 4)Ended earlyNCT01315886
What this trial is testing

Conversion From Fast Acting Oral Opioids to Abstral®

Who this might be right for
Pain
Orexo AB 8
Not applicableStudy completedNCT04595032
What this trial is testing

MAnagement of METastatic Disease in Campania (MAMETIC)

Who this might be right for
Metastatic Disease
National Cancer Institute, Naples 3,234
Early research (Phase 1)Study completedNCT00125294
What this trial is testing

Sublingual Methadone for the Management of Cancer Breakthrough Pain

Who this might be right for
CancerPain
AHS Cancer Control Alberta 10
Large-scale testing (Phase 3)Study completedNCT00683995
What this trial is testing

A Phase III Clinical Study of KW-2246

Who this might be right for
Pain, Cancer
Kyowa Kirin Co., Ltd. 43
Large-scale testing (Phase 3)Study completedNCT00496392
What this trial is testing

Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)

Who this might be right for
Pain
Nycomed 115
Large-scale testing (Phase 3)UnknownNCT00822614
What this trial is testing

Safety of Fentanyl TAIFUN Treatment

Who this might be right for
Breakthrough Cancer Pain
Akela Pharma, Inc. 500
Large-scale testing (Phase 3)Ended earlyNCT02591017
What this trial is testing

Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain Outpatients

Who this might be right for
Cancer: Breakthrough PainCancer: Extreme Pain on Movement
University Hospital, Basel, Switzerland 11
Large-scale testing (Phase 3)Study completedNCT00458510
What this trial is testing

Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain

Who this might be right for
Cancers, Pain
Archimedes Development Ltd 403
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT01439919
What this trial is testing

A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain

Who this might be right for
PainBreakthrough Cancer Pain
Sanofi 5
Not applicableUnknownNCT02069067
What this trial is testing

Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated

Who this might be right for
Advanced Cancer
National Cancer Institute, Naples 500
Not applicableStudy completedNCT02382653
What this trial is testing

Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain

Who this might be right for
Neoplasm Metastases
Tanta University 100
Large-scale testing (Phase 3)Study completedNCT00105287
What this trial is testing

Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Who this might be right for
PainCancer
Cephalon 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation